期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 369, 期 25, 页码 2457-2457出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa1206168
关键词
-
To the Editor: The meta-analysis by Shlipak et al. (Sept. 5 issue)(1) shows that a cystatin C-based estimated glomerular filtration rate (eGFR) offers improvements in predicting risks of death and end-stage renal disease across diverse populations. In their editorial, Ingelfinger and Marsden(2) caution that results cannot be applied to Asian and Hispanic patients except by extrapolation. Also, diabetes was underrepresented in the sample of patients with chronic kidney disease; it was present in only 9% of participants. Further, more information is still needed about the use of cystatin C in pregnant women, patients who have undergone renal transplantation, and children. ...
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据